Figure 8 Investment Strategies LLC Makes New $538,000 Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Figure 8 Investment Strategies LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 7,772 shares of the company's stock, valued at approximately $538,000.

Other institutional investors also recently modified their holdings of the company. Sanctuary Advisors LLC acquired a new stake in shares of Henry Schein in the 2nd quarter valued at $351,000. Bfsg LLC bought a new position in shares of Henry Schein during the 3rd quarter worth about $205,000. Cardinal Capital Management increased its holdings in shares of Henry Schein by 6.4% during the 3rd quarter. Cardinal Capital Management now owns 14,202 shares of the company's stock worth $1,035,000 after purchasing an additional 857 shares during the period. Marathon Asset Management Ltd increased its stake in Henry Schein by 3.2% in the third quarter. Marathon Asset Management Ltd now owns 279,203 shares of the company's stock valued at $20,354,000 after acquiring an additional 8,742 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Henry Schein by 2.7% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 12,994 shares of the company's stock valued at $947,000 after acquiring an additional 340 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

HSIC stock traded up $1.63 during trading hours on Tuesday, reaching $77.63. The stock had a trading volume of 2,573,709 shares, compared to its average volume of 1,480,900. The stock has a market capitalization of $9.68 billion, a PE ratio of 31.95, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a 50-day simple moving average of $74.03 and a 200 day simple moving average of $72.02. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective on the stock. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Barrington Research increased their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a report on Thursday, January 30th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of "Moderate Buy" and an average target price of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.